Search
for
Sort by
Research 721–750 of 1000+
- Distinct Developmental Functions of Prostasin (CAP1/PRSS8) Zymogen and Activated Prostasin
- Androgenic alopecia is not useful as an indicator of men at high risk of prostate cancer
- Hormonal prevention of prostate cancer
- Rare Germline Pathogenic Variants Identified by Multigene Panel Testing and the Risk of Aggressive Prostate Cancer
- Apocrine sweat gland obstruction by antiperspirants allowing transdermal absorption of cutaneous generated hormones and pheromones as a link to the observed incidence rates of breast and prostate cancer in the 20th century
- The Relationship Between Metformin and Serum Prostate‐Specific Antigen Levels
- Age-Dependent Associations between Androgenetic Alopecia and Prostate Cancer Risk
- Is prostate-specific antigen a potential new marker of androgen excess in polycystic ovary syndrome?
- Association between prostate‐specific antigen and serum testosterone: A systematic review and meta‐analysis
- Abiraterone and spironolactone in prostate cancer: a combination to avoid
- Erosive pustular dermatosis of the scalp after contact dermatitis from a prosthetic hair piece
- Androgen Receptor Polymorphism-Dependent Variation in Prostate-Specific Antigen Concentrations of European Men
- Increased DHT levels in androgenic alopecia have been selected for to protect men from prostate cancer
- Prostate-Specific Antigen as a Marker of Hyperandrogenism in Women and Its Implications for Antidoping
- Prostate specific antigen (PSA) in diagnosis of polycystic ovarian syndrome – a new insight
- Interaction between estrogens and androgen receptor genes microsatellites, prostate-specific antigen and androgen receptor expressions in breast cancer
- Prostate cancer update: 2007
- Androgenic alopecia may have evolved to protect men from prostate cancer by increasing skin exposure to ultraviolet radiation
- Advances in structure-based drug design targeting membrane protein markers in prostate cancer
- Salvage Therapy for Prostate Cancer: AUA/ASTRO/SUO Guideline Part II: Treatment Delivery for Non-metastatic Biochemical Recurrence After Primary Radical Prostatectomy
- Imaging prostate cancer (PCa) with [<sup>99m</sup> Tc(CO)<sub>3</sub> ]finasteride dithiocarbamate
- The association of male pattern baldness and risk of cancer and high-grade disease among men presenting for prostate biopsy
- Hair, Hormones, and High-Risk Prostate Cancer
- TMPRSS2, required for SARS-CoV-2 entry, is downregulated in lung cells by enzalutamide, a prostate cancer therapeutic
- Effect of flutamide and two novel synthetic steroids on GABA, glutamine and some oxidative stress markers in rat brain and prostate
- An Overview of Chemotherapy Side Effects on Patients with Prostate Cancer, Bladder Cancer, and Testicular Cancer at Haji Adam Malik General Hospital Medan from 2020-2022
- Finasteride Counseling for Male Androgenetic Alopecia Should Reflect Updated Findings on Prostate Cancer Risk
- Serum androgens and prostate-specific antigen levels in androgenetic alopecia: is there a difference between frontal and vertex baldness?
- Co-option of Hair Follicle Keratins into Amelogenesis Is Associated with the Evolution of Prismatic Enamel: A Hypothesis
- Researchers Link Early Hair Loss and Prostate Cancer